<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To investigate the association between the <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> E (APOE) genotypes and <z:hpo ids='HP_0000726'>dementia</z:hpo> in patients with <z:hpo ids='HP_0001297'>stroke</z:hpo>, defined as either vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (VaD) or <z:hpo ids='HP_0002511'>Alzheimer disease</z:hpo> with cerebrovascular disease (AD with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>DESIGN AND SETTING: Population-based, case-control study from Rotterdam, the Netherlands, and New York City </plain></SENT>
<SENT sid="2" pm="."><plain>PARTICIPANTS: A total of 187 patients with <z:hpo ids='HP_0000726'>dementia</z:hpo> and <z:hpo ids='HP_0001297'>stroke</z:hpo> were compared with 507 controls similar in age and ethnic group </plain></SENT>
<SENT sid="3" pm="."><plain>MAIN OUTCOME MEASURES: The APOE allele frequencies in patients and controls; the odds ratio of <z:hpo ids='HP_0000726'>dementia</z:hpo> with <z:hpo ids='HP_0001297'>stroke</z:hpo>, VaD, and AD with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>, adjusted for age, sex, residency, and education; and the percent attributable risk related to the APOE epsilon4 allele </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Overall, patients with <z:hpo ids='HP_0000726'>dementia</z:hpo> and <z:hpo ids='HP_0001297'>stroke</z:hpo> had a higher APOE epsilon4 allele frequency than controls </plain></SENT>
<SENT sid="5" pm="."><plain>Compared with APOE epsilon3 homozygote individuals, APOE epsilon4 homozygotes had a 7-fold increased risk of <z:hpo ids='HP_0000726'>dementia</z:hpo> with <z:hpo ids='HP_0001297'>stroke</z:hpo> (OR=6.9; 95% CI, 1.6-29.4), while APOE epsilon4 heterozygotes had nearly a 2-fold increase in risk (OR=1.8; 95% CI, 1.2-2.7) </plain></SENT>
<SENT sid="6" pm="."><plain>Risks associated with APOE epsilon4 were elevated regardless of the subtype of <z:hpo ids='HP_0000726'>dementia</z:hpo> with <z:hpo ids='HP_0001297'>stroke</z:hpo> or age or sex </plain></SENT>
<SENT sid="7" pm="."><plain>The percent attributable risk related to the APOE epsilon4 allele among <z:e sem="disease" ids="C0860630" disease_type="Mental or Behavioral Dysfunction" abbrv="">demented</z:e> patients with <z:hpo ids='HP_0001297'>stroke</z:hpo> was 41% overall, 33% among those with VaD, and 44% among those with AD with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: The APOE epsilon4 allele is a genetic risk factor for <z:hpo ids='HP_0000726'>dementia</z:hpo> with <z:hpo ids='HP_0001297'>stroke</z:hpo>, including VaD and AD with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>This may imply shared genetic susceptibility to <z:hpo ids='HP_0000726'>dementia</z:hpo> associated with <z:hpo ids='HP_0001297'>stroke</z:hpo> and AD </plain></SENT>
<SENT sid="10" pm="."><plain>Alternatively, the category of patients with <z:hpo ids='HP_0000726'>dementia</z:hpo> and <z:hpo ids='HP_0001297'>stroke</z:hpo>, including VaD as currently defined, may include patients with AD </plain></SENT>
</text></document>